SCHEMBL5041962

SCHEMBL5041962

COC(C(=O)NCc1ccc(C#N)cc1)c1cc(C)ccc1F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.50
HIF1A Q16665 1/20 0.43
KMT2A Q03164 3/20 0.41
EPHX2 P34913 1/20 0.40
AKR1C3 P42330 1/20 0.39
VNN1 O95497 1/20 0.39
GAA P10253 1/20 0.38
AKR1B1 P15121 1/20 0.38
SLC1A3 P43003 1/20 0.38
SLC1A2 P43004 1/20 0.38
MMP2 P08253 1/20 0.38
MMP3 P08254 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
GSK3B P49841 1/20 0.38
MEN1 O00255 2/20 0.38
KLKB1 P03952 1/20 0.37
KLK1 P06870 1/20 0.37
ALDH1A1 P00352 1/20 0.37
SCN5A Q14524 1/20 0.37
SCN9A Q15858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5041968 1.00 PKM (0.50) PKMHIF1AKMT2AEPHX2AKR1C3
SCHEMBL5040766 0.89 HIF1A (0.43) PKMHIF1AEPHX2GAAAKR1B1
SCHEMBL5040763 0.89 HIF1A (0.43) PKMHIF1AEPHX2GAAAKR1B1
SCHEMBL5047826 0.88 HIF1A (0.44) PKMHIF1AVNN1GAAL3MBTL1
SCHEMBL5047829 0.88 HIF1A (0.44) PKMHIF1AVNN1GAAL3MBTL1
SCHEMBL5043244 0.86 EPHX2 (0.45) PKMHIF1AEPHX2VNN1
SCHEMBL5043243 0.86 EPHX2 (0.45) PKMHIF1AEPHX2VNN1
SCHEMBL5040859 0.85 PKM (0.47) PKMHIF1AAKR1C3SLC1A3SLC1A2
SCHEMBL5040862 0.85 PKM (0.47) PKMHIF1AAKR1C3SLC1A3SLC1A2
SCHEMBL5038067 0.85 HIF1A (0.52) PKMHIF1AEPHX2GAASLC1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
EP-1567498-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-31 EP disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed
WO-2004048335-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 PKM 4225/4885HIF1A 251/4885KMT2A 1963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.